Dexlansoprazole: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Dexlansoprazole. Educational only — not medical advice.
Reported adverse reactions
| Reaction | Highest frequency reported* |
|---|---|
| Diarrhea | 5.1% |
| Abdominal pain | 4% |
| Nausea | 3.3% |
| Upper respiratory tract infection | 2.9% |
| Flatulence | 2.6% |
| Vomiting | 2.2% |
*Highest percentage across placebo-controlled trial tables summarized in current labeling.
Labeled uses
1.1 Healing of Erosive EsophagitisKAPIDEX is indicated for healing of all grades of erosive esophagitis (EE) for up to 8 weeks. 1.2 Maintenance of Healed Erosive EsophagitisKAPIDEX is indicated to maintain healing of EE for up to 6 months. 1.3 Symptomatic Non-Erosive Gastroesophageal Reflux DiseaseKAPIDEX is indicated for the treatment of heartburn associated with non-erosive gastroesophageal reflux disease (GERD) for 4 weeks.
Source: FDA labeling via NIH DailyMed (set c83616c9…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.